Camps-Vilaro, A, Perez-Fernandez, S, Subirana, I, Teira, R, Estrada, V, Domingo, P, Degano, IR, Marrugat, J. Standardized Comparison of Cardiovascular Risk Factors Prevalence in Spanish Women and Men Living with HIV and in the General Population. Journal of Personalized Medicine. 2021; 11(11)DOI:10.3390/jpm11111085. PMID:34834438. IF:3.508(Q2/4D).

Nomah, DK, Reyes-Uruena, J, Diaz, Y, Moreno, S, Aceiton, J, Bruguera, A, Vivanco-Hidalgo, RM, Llibre, JM, Domingo, P, Falco, V, Imaz, A, Cortes, C, Force, L, Letang, E, Vilaro, I, Casabona, J, Miro, JM, Mur I., Macorigh, Lizza. Sociodemographic, clinical, and immunological factors associated with SARS-CoV-2 diagnosis and severe COVID-19 outcomes in people living with HIV: a retrospective cohort study. Lancet HIV. 2021; 8(11)DOI:10.1016/S2352-3018(21)00240-X. PMID:34655549. IF:16.070(Q1/1D).

Kowalska, JD, Pelchen-Matthews, A, Ryom, L, Losso, MH, Trofimova, T, Mitsura, VM, Khromova, I, Paduta, D, Stephan, C, Domingo, P, Bakowska, E, Monforte, AD, Oestergaard, L, Jablonowska, E, Kuznetsova, A, Moreno, S, Vasylyev, M, Pradier, C, Battegay, M, Vandekerckhove, L, Castagna, A, Raben, D, Mocroft, A, EuroSIDA Study Grp. Prevalence and outcomes of pregnancies in women with HIV over a 20-year period. AIDS. 2021; 35(12)DOI:10.1097/QAD.0000000000002954. PMID:34033590. IF:4.632(Q2/5D).

Arroyo-Diaz, JA, Julve, J, Vlacho, B, Corcoy, R, Ponte, P, Roman, E, Navas-Mendez, E, Llaurado, G, Franch-Nadal, J, Domingo, P, Mauricio, D. Previous Vitamin D Supplementation and Morbidity and Mortality Outcomes in People Hospitalised for COVID19: A Cross-Sectional Study. Frontiers in Public Health. 2021; 9DOI:10.3389/fpubh.2021.758347. PMID:34631653. IF:6.461(Q1/2D).

Teira, R, Diaz-Cuervo, H, Aragao, F, Munoz, J, Galindo, P, Merino, M, de la Fuente, B, Sepulveda, MA, Domingo, P, Garcia, J, Castano, M, Ribera, E, Geijo, P, Romero, A, Peraire, J, Deig, E, Roca, B, Martinez, E, Estrada, V, Montero, M, Berenguer, J, Espinosa, N. eGFR-EPI changes among HIV patients who switch from F/TDF to F/TAF while maintaining the same third agent in the Spanish VACH cohort. HIV Research & Clinical Practice. 2021; 22(3)DOI:10.1080/25787489.2021.1955197. PMID:34410219. IF:1.676(Q4/9D).

Gonzalez-Cordon, A, Assoumou, L, Moyle, G, Waters, L, Johnson, M, Domingo, P, Fox, J, Stellbrink, HJ, Guaraldi, G, Masia, M, Gompels, M, De Wit, S, Florence, E, Esser, S, Raffi, F, Behrens, G, Pozniak, A, Gatell, JM, Martinez, E. Switching from boosted PIs to dolutegravir decreases soluble CD14 and adiponectin in high cardiovascular risk people living with HIV. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY. 2021; 76(9)DOI:10.1093/jac/dkab158. PMID:34120186. IF:5.758(Q1/2D).

Palacio-Vieira, J, Reyes-Uruena, JM, Imaz, A, Bruguera, A, Force, L, Llaveria, AO, Llibre, JM, Vilaro, I, Borras, FH, Falco, V, Riera, M, Domingo, P, de Lazzari, E, Miro, JM, Casabona, J, Gurgui M., Hernandez, J.. Strategies to reengage patients lost to follow up in HIV care in high income countries, a scoping review. BMC PUBLIC HEALTH. 2021; 21(1)DOI:10.1186/s12889-021-11613-y. PMID:34454444. IF:4.135(Q2/4D).

Rojas, J, de Lazzari, E, Negredo, E, Domingo, P, Tiraboschi, J, Ribera, E, Abdulghani, N, Puig, J, Mateo, MG, Podzamczer, D, Gutierrez, MM, Paredes, R, Clotet, B, Gatell, JM, Blanco, JL, Martinez, E, DOLAM Study Grp. Efficacy and safety of switching to dolutegravir plus lamivudine versus continuing triple antiretroviral therapy in virologically suppressed adults with HIV at 48 weeks (DOLAM): a randomised non-inferiority trial. Lancet HIV. 2021; 8(8)DOI:10.1016/S2352-3018(21)00100-4. PMID:34358497. IF:16.070(Q1/1D).

Domingo, P, Pomar, V, Mur, I, Castellvi, I, Corominas, H, de Benito, N. Not all COVID-19 pandemic waves are alike. CLINICAL MICROBIOLOGY AND INFECTION. 2021; 27(7)DOI:10.1016/j.cmi.2021.04.005. PMID:33887469. IF:13.310(Q1/1D).

Domingo, P, Giralt, M, Gavalda-Navarro, A, Blasco-Roset, A, Delgado-Angles, A, Gallego-Escuredo, JM, Gutierrez, MD, Mateo, MG, Cereijo, R, Domingo, JC, Villarroya, F, Villarroya, J. Adipose tissue aging partially accounts for fat alterations in HIV lipodystrophy. Adipocyte. 2022; 11(1)DOI:10.1080/21623945.2022.2042962. PMID:35300561. IF:3.300(Q3/6D).

Llaurado, G, Vlacho, B, Wargny, M, Ruan, Y, Franch-Nadal, J, Domingo, P, Gourdy, P, Saulnier, PJ, Hadjadj, S, Wild, SH, Rea, R, Cariou, B, Khunti, K, Mauricio, D. The association between macrovascular complications and intensive care admission, invasive mechanical ventilation, and mortality in people with diabetes hospitalized for coronavirus disease-2019 (COVID-19). Cardiovascular Diabetology. 2022; 21(1)DOI:10.1186/s12933-022-01657-8. PMID:36261811. IF:9.300(Q1/1D).

Spinner, CD, Felizarta, F, Rizzardini, G, Philibert, P, Mitha, E, Domingo, P, Stephan, CJ, DeGrosky, M, Bainbridge, V, Zhan, J, Dumitrescu, TP, Jeffrey, JL, Xu, JF, Halliday, F, Gan, JJ, Johnson, M, Gartland, M, Joshi, SR, Lataillade, M. Phase IIa Proof-of-Concept Evaluation of the Antiviral Efficacy, Safety, Tolerability, and Pharmacokinetics of the Next-Generation Maturation Inhibitor GSK3640254. CLINICAL INFECTIOUS DISEASES. 2022; 75(5)DOI:10.1093/cid/ciab1065. PMID:34996113. IF:11.800(Q1/1D).

Castellvi, I, Castillo, D, Corominas, H, Mariscal, A, Orozco, S, Benito, N, Pomar, V, Baucells, A, Mur, I, de la Rosa-Carrillo, D, Lobo, D, Millan, AM, de Sosa, NH, Filella, D, Matas, L, Martinez-Martinez, L, Juarez, C, Casademont, J, Domingo, P. Krebs von den Lungen-6 glycoprotein circulating levels are not useful as prognostic marker in COVID-19 pneumonia: A large prospective cohort study. Frontiers in Medicine. 2022; 9DOI:10.3389/fmed.2022.973918. PMID:36004366. IF:3.900(Q2/4D).

Masip, J, Jorba, R, Lopez-Dupla, M, Domingo, P, Pacheco, YM, Garcia-Pardo, G, Martinez, E, Vilades, C, Veloso, S, Alba, V, Olona, M, Vidal, F, Gomez-Bertomeu, F, Peraire, J, Rull, A. Lipoprotein Profile in Immunological Non-Responders PLHIV after Antiretroviral Therapy Initiation. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES. 2022; 23(15)DOI:10.3390/ijms23158071. PMID:35897644. IF:5.600(Q1/3D).

Nomah, DK, Reyes-Uruena, J, Diaz, Y, Moreno, S, Aceiton, J, Bruguera, A, Vivanco-Hidalgo, RM, Casabona, J, Domingo, P, Navarro, J, Imaz, A, Deig, E, Navarro, G, Llibre, JM, Miro, JM. Impact of tenofovir on SARS-CoV-2 infection and severe outcomes among people living with HIV: a propensity score-matched study. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY. 2022; 77(8)DOI:10.1093/jac/dkac177. PMID:35678461. IF:5.200(Q1/3D).

Franquet, T, Gimenez, A, Ketai, L, Mazzini, S, Rial, A, Pomar, V, Domingo, P. Air trapping in COVID-19 patients following hospital discharge: retrospective evaluation with paired inspiratory/expiratory thin-section CT. EUROPEAN RADIOLOGY. 2022; 32(7)DOI:10.1007/s00330-022-08580-2. PMID:35226158. IF:5.900(Q1/2D).

Saumoy, M, Sanchez-Quesada, JL, Assoumou, L, Gatell, JM, Gonzalez-Cordon, A, Guaraldi, G, Domingo, P, Giacomelli, A, Connault, J, Katlama, C, Masia, M, Ordonez-Llanos, J, Pozniak, A, Martinez, E, Podzamczer, D. Atherogenicity of low-density lipoproteins after switching from a protease inhibitor to dolutegravir: a substudy of the NEAT022 study. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY. 2022; 77(7)DOI:10.1093/jac/dkac117. PMID:35411401. IF:5.200(Q1/3D).

Moga, E, Lynton-Pons, E, Domingo, P. The Robustness of Cellular Immunity Determines the Fate of SARS-CoV-2 Infection. Frontiers in Immunology. 2022; 13DOI:10.3389/fimmu.2022.904686. PMID:35833134. IF:7.300(Q1/3D).

Franquet, T, Domingo, P. Pulmonary Infections in People Living with HIV. RADIOLOGIC CLINICS OF NORTH AMERICA. 2022; 60(3)DOI:10.1016/j.rcl.2022.01.008. PMID:35534134. IF:1.900(Q3/8D).

Podzamczer, D, Mican, R, Tiraboschi, J, Portilla, J, Domingo, P, Llibre, JM, Ribera, E, Vivancos, MJ, Morano, L, Masia, M, Gomez, C, Fanjul, F, Payeras, A, Inciarte, A, Estrada, V, Rivero, A, Castro, A, Bernal, E, Vinuesa, D, Knobel, H, Troya, J, Macias, J, Montero, M, Sanz, J, Navarro-Alcaraz, A, Caicedo, A, Fernandez, G, Martinez, E, Moreno, S. Darunavir/Cobicistat/Emtricitabine/Tenofovir Alafenamide Versus Dolutegravir/Abacavir/Lamivudine in Antiretroviral-Naive Adults (SYMTRI): A Multicenter Randomized Open-Label Study (PReEC/RIS-57). Open Forum Infectious Diseases. 2022; 9(3)DOI:10.1093/ofid/ofab595. PMID:35237700. IF:4.200(Q2/4D).

Garcia-Beltran, C, Cereijo, R, Plou, C, Gavalda-Navarro, A, Malpique, R, Villarroya, J, Lopez-Bermejo, A, de Zegher, F, Ibanez, L, Villarroya, F. Posterior Cervical Brown Fat and CXCL14 Levels in the First Year of Life: Sex Differences and Association With Adiposity. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM. 2022; 107(3)DOI:10.1210/clinem/dgab761. PMID:34677618. IF:5.800(Q1/3D).

Domingo, P, Mateo, MG, Villarroya, J, Cereijo, R, Torres, F, Domingo, JC, Campderros, L, Gallego-Escuredo, JM, Gutierrez, MD, Mur, I, Corbacho, N, Vidal, F, Villarroya, F, Giralt, M. Increased Circulating Levels of Growth Differentiation Factor 15 in Association with Metabolic Disorders in People Living with HIV Receiving Combined Antiretroviral Therapy. Journal of Clinical Medicine. 2022; 11(3)DOI:10.3390/jcm11030549. PMID:35160008. IF:3.900(Q2/4D).

Yeregui, E, Masip, J, Vilades, C, Domingo, P, Pacheco, YM, Blanco, J, Mallolas, J, Alba, V, Vargas, M, Garcia-Pardo, G, Negredo, E, Olona, M, Vidal-Gonzalez, J, Peraire, M, Marti, A, Reverte, L, Gomez-Bertomeu, F, Leal, M, Vidal, F, Peraire, J, Rull, A. Adipokines as New Biomarkers of Immune Recovery: Apelin Receptor, RBP4 and ZAG Are Related to CD4(+) T-Cell Reconstitution in PLHIV on Suppressive Antiretroviral Therapy. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES. 2022; 23(4)DOI:10.3390/ijms23042202. PMID:35216318. IF:5.600(Q1/3D).

Collazos, J, Domingo, P, Fernandez-Araujo, N, Asensi-Diaz, E, Vilchez-Rueda, H, Lalueza, A, Roy-Vallejo, E, Blanes, R, Raya-Cruz, M, Sanz-Canovas, J, Artero, A, Ramos-Rincon, JM, Duenas-Gutierrez, C, Lamas-Ferreiro, JL, Asensi, V. Exposure to valproic acid is associated with less pulmonary infiltrates and improvements in diverse clinical outcomes and laboratory parameters in patients hospitalized with COVID-19. PLoS One. 2022; 17(1)DOI:10.1371/journal.pone.0262777. PMID:35085321. IF:3.700(Q2/4D).

Domingo, P, de Benito, N. Alpha variant SARS-CoV-2 infection: How it all starts. EBioMedicine. 2021; 74DOI:10.1016/j.ebiom.2021.103703. PMID:34800902. IF:11.205(Q1/2D).

Camps-Vilaró, A, Teira, R, Subirana, I, Dégano, IR, Domingo, P, Curran, A, Montero-Alonso, M, Romero, A, Marrugat, J, Galindo, MJ. Age-standardized comparison of coronary artery disease, stroke incidence, and all-cause mortality between people living with HIV and the general population in Spain. INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES. 2025; 160DOI:10.1016/j.ijid.2025.108061. PMID:40953693. IF:4.300(Q1/2D).

de Lazzari, E, Di Gregorio, S, Rojas, J, Curran, A, Domingo, P, Negredo, E, Tiraboschi, J, Gonzalez-Cordon, A, Torres, B, Sempere, A, Inciarte, A, Gatell, JM, Blanco, JL, Martinez, E. 48 Week body composition changes in persons with HIV switching to dolutegravir plus lamivudine: a planned subanalysis of the DOLAM randomized clinical trial. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY. 2025; 80(8)DOI:10.1093/jac/dkaf192. PMID:40556520. IF:3.600(Q2/3D).

Giralt, M, Domingo, P, Quesada-López, T, Cereijo, R, Villarroya, F. Lipodystrophy in HIV: Evolving Challenges and Unresolved Questions. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES. 2025; 26(14)DOI:10.3390/ijms26146546. PMID:40724797. IF:4.900(Q1/3D).

Ryan, P, Blanco, JL, Masia, M, Garcia-Fraile, L, Crusells, MJ, Domingo, P, Curran, A, Guerri-Fernandez, R, Bernal, E, Bravo, J, Revollo, B, Macias, J, Tiraboschi, JM, Montejano, R, Amador, C, Torralba, M, Merino, D, Diaz-Brito, V, Galindo, MJ, Ferra, S, Villoslada, A, Losa, JE, Fanjul, FJ, Perez-Stachowski, X, Peraire, J, Portilla, J, de la Fuente, S, Dueñas, C, Vazquez, MJ, Di Gregorio, S, Esteban, H, Gil, P, de Miguel, M, Alejos, B, Martínez, E. Maintenance therapy with dolutegravir and lamivudine versus bictegravir, emtricitabine, and tenofovir alafenamide in people with HIV (PASO-DOBLE): 48-week results from a randomised, multicentre, open-label, non-inferiority trial. Lancet HIV. 2025; 12(7)DOI:10.1016/S2352-3018(25)00105-5. PMID:40489982. IF:13.000(Q1/1D).

Rogg, L, Nuñez, SA, Mingrone, MVO, Domingo, P, Lopez, M, Hanan, N, Ghita, GL, Jeffrey, JL, Underwood, M, Castillo-Mancilla, JR, Halliday, F, Ezeadi, E, Gartland, M. Antiviral effect, safety, and tolerability of the third-generation integrase strand transfer inhibitor VH4524184 (VH-184): a proof-of-concept trial. HIV MEDICINE. 2025; 26DOI:. PMID:. IF:3.200(Q2/4D).

Bailón, L, Moltó, J, Curran, A, Cadiñanos, J, de Quirós, JCLB, de los Santos, I, Ambrosioni, J, Imaz, A, Benet, S, Suanzes, P, Navarro, J, González-García, J, Busca, C, Pérez-Latorre, L, Berenguer, J, García-Fraile, LJ, Mejia-Abril, G, Miró, JM, Scévola, S, Moreno, S, Domingo, P, Tian, Y, Frankot, M, Lim, D, Cai, YH, Vendrame, E, Guo, S, Wallin, JJ, Geleziunas, R, Sengupta, D, Alarcón-Soto, Y, Leal, I, Aranguen, A, Garcia-Garcia, M, McGowan, I, Brander, C, Arribas, JR, Mothe, B. Safety, immunogenicity and effect on viral rebound of HTI vaccines combined with a TLR7 agonist in early-treated HIV-1 infection: a randomized, placebo-controlled phase 2a trial. Nature Communications. 2025; 16(1)DOI:10.1038/s41467-025-57284-w. PMID:40038256. IF:15.700(Q1/1D).

Suades, R, Greco, MF, Padró, T, de Santisteban, V, Domingo, P, Benincasa, G, Napoli, C, Greco, S, Madè, A, Ranucci, M, Devaux, Y, Martelli, F, Badimon, L. Blood CD45+/CD3+ lymphocyte-released extracellular vesicles and mortality in hospitalized patients with coronavirus disease 2019. EUROPEAN JOURNAL OF CLINICAL INVESTIGATION. 2025; 55(2)DOI:10.1111/eci.14354. PMID:39548690. IF:3.600(Q1/2D).

Bruguera, A, Nomah, DK, Moreno-Fornés, S, Martinez, E, Negredo, E, Tiraboschi, J, Navarro, J, Domingo, P, Fanjul, F, Villoslada, A, Peraire, J, Jaen, A, Miró JM, Casabona, J, Reyes-Urueña, J. Epidemiological, clinical and mortality trends in people with HIV over 60 years in the PISCIS population-based cohort from Catalonia and Balearic Islands. AIDS. 2025; 39(1)DOI:10.1097/QAD.0000000000004018. PMID:39639721. IF:3.100(Q2/4D).

Pan Y.-H., Nomah D.K., Montoro-Fernandez M., Moreno-Fornés S., Díaz Y., Aceitón J., Bruguera A., Llibre J.M., Domingo P., Imaz A., Vilaró I., Falcó V., Reyes-Urueña J., Miro J.M., Casabona J.. The impact of the COVID-19 pandemic on healthcare services utilization among people living with HIV in Catalonia, Spain: A population-based cohort study. ENFERMEDADES INFECCIOSAS Y MICROBIOLOGIA CLINICA. 2024; 42(10)DOI:10.1016/j.eimc.2023.09.001. PMID:38218704. IF:2.500(Q2/5D).

Karaduzovic-Hadziabdic, K, Adilovic, M, Zhang, L, Lumley, A, Shah, PA, Shoaib, M, Satagopam, V, Srivastava, PK, Emanueli, C, Greco, S, Made, A, Padro, T, Domingo, P, Lustrek, M, Scholz, M, Rosolowski, M, Jordan, M, Benczik, B, Agg, B, Ferdinandy, P, Baker, AH, Fagherazzi, G, Ollert, M, Michel, J, Sanchez, G, Firat, H, Brandenburger, T, Martelli, F, Badimon, L, Devaux, Y. Prediction of COVID-19 severity using machine learning. Clinical and Translational Medicine. 2024; 14(10)DOI:10.1002/ctm2.70042. PMID:39370709. IF:6.800(Q1/2D).

Díaz, M, Quesada, T, Villarroya, F, López-Bermejo, A, Casano, P, De Zegher, F, Ibanez, L. The proteome of circulating exosomes in appropriate- versus small-for-gestational-age infants: differentially expressed proteins at birth associate with measures of weight gain, liver fat, insulin resistance and adrenarche at age 7. Hormone Research in Paediatrics. 2024; 97DOI:. PMID:. IF:2.700(Q1/2D).

Suades, R, Greco, MF, Prieto, P, Padro, T, Devaux, Y, Domingo, P, Badimon, L. CD66b⁺/CD68⁺ circulating extracellular vesicles, lactate dehydrogenase and neutrophil-to-lymphocyte ratio can differentiate coronavirus disease 2019 severity during and after infection. Journal of Extracellular Vesicles. 2024; 13(7)DOI:10.1002/jev2.12456. PMID:39007437. IF:14.500(Q1/1D).

Ryan, P, Blanco, JL, Masia, M, Garcia-Fraile, L, Crusells, MJ, Domingo, P, Curran, A, Guerri-Fernandez, R, Bernal, E, Bravo, J, Revollo, B, Macias, J, Tiraboschi, JM, Montejano, R, Amador, C, Torralba, M, Merino, D, Diaz-Brito, V, Galindo, MJ, Ferra, S, Villoslada, A, Losa, JE, Fanjul, FJ, Perez-Stachowski, J, Peraire, J, Portilla, J, de la Fuente, S, Dueñas, C, Vazquez, MJ, Di Gregorio, S, Manzanares, E, Gil, P, de Miguel, M, Alejos, B, Martinez, E. Non-inferior efficacy and less weight gain when switching to DTG/3TC than when switching to BIC/FTC/TAF in virologically suppressed people with HIV (PWH): the PASO-DOBLE (GeSIDA 11720) randomized clinical trial. Journal of the International AIDS Society. 2024; 27DOI:. PMID:. IF:4.900(Q1/2D).

Suades, R, Padró, T, Domingo, P, Greco, MF, Benincasa, G, Greco, S, Madè, A, Ranucci, M, Devaux, Y, Martelli, F, Badimon, L. Blood immune and endothelial cell-released extracellular vesicle changes relate to COVID-19 mortality in hospitalized patients. EUROPEAN JOURNAL OF CLINICAL INVESTIGATION. 2024; 54DOI:. PMID:. IF:3.600(Q1/2D).

Berenguer, J, Jarrín, I, Bellón, JM, Díez, C, Jiménez-Sousa, MA, López, JC, Pinto-Martínez, A, Moreno, S, Montes, ML, Iribarren, JA, Orviz, E, Portilla, J, Villarroya, F, Domingo, P, Resino, S. Mitochondrial Haplogroups and Weight Gain After Initiating ART in Patients With HIV. JOURNAL OF INFECTIOUS DISEASES. 2024; 230(2)DOI:10.1093/infdis/jiae168. PMID:38557859. IF:4.500(Q1/2D).

Castellá, M, Mestres-Arenas, A, Gavaldà-Navarro, A, Blasco-Roset, A, Quesada-López, T, Romero-Carramiñana, I, Giralt, M, Villarroya, F, Cereijo, R. The splicing factor SF3B1 is involved in brown adipocyte thermogenic activation. BIOCHEMICAL PHARMACOLOGY. 2024; 220DOI:10.1016/j.bcp.2023.116014. PMID:38158020. IF:5.600(Q1/1D).

Díaz, M, Casano, P, Quesada, T, López-Bermejo, A, de Zegher, F, Villarroya, F, Ibáñez, L. Circulating exosomes decrease in size and increase in number between birth and age 7: relations to fetal growth and liver fat. Frontiers in Endocrinology. 2023; 14DOI:10.3389/fendo.2023.1257768. PMID:38027180. IF:3.900(Q2/3D).

Santos, JR, Domingo, P, Portilla, J, Gutiérrez, F, Imaz, A, Vilchez, H, Curran, A, Valcarce-Pardeiro, N, Payeras, A, Bernal, E, Montero-Alonso, M, Yzusqui, M, Clotet, B, Videla, S, Moltó, J, Paredes, R. A Randomized Trial of Dolutegravir Plus Darunavir/Cobicistat as a Switch Strategy in HIV-1-Infected Patients With Resistance to at Least 2 Antiretroviral Classes. Open Forum Infectious Diseases. 2023; 10(11)DOI:10.1093/ofid/ofad542. PMID:38023553. IF:3.800(Q2/3D).

Bruguera, A, Nomah, D, Moreno-Fornis, S, Diaz, Y, Aceiton, J, Reyes-Uruena, J, Ambrosioni, J, Llibre, JM, Falco, V, Imaz, A, Fanjul, F, Navarro, G, Pere, D, Leon, E, Mera, A, Miro, JM, Casabona, J. Cohort Profile: PISCIS, a population-based cohort of people living with HIV in Catalonia and Balearic Islands. INTERNATIONAL JOURNAL OF EPIDEMIOLOGY. 2023; 52(4)DOI:10.1093/ije/dyad083. PMID:37403345. IF:6.400(Q1/1D).

Santos J.R., Casadellà M., Noguera-Julian M., Micán-Rivera R., Domingo P., Antela A., Portilla J., Sanz J., Montero-Alonso M., Navarro J., Masiá M., Valcarce-Pardeiro N., Ocampo A., Pérez-Martínez L., García-Vallecillos C., Vivancos M.J., Imaz A., Iribarren J.A., Hernández-Quero J., Villar-García J., Barrufet P., Paredes R.. Effectiveness and safety of integrase strand transfer inhibitors in Spain: a prospective real-world study. Frontiers in Cellular and Infection Microbiology. 2023; 13DOI:10.3389/fcimb.2023.1187999. PMID:37434782. IF:4.600(Q1/3D).

Castella, M, Blasco-Roset, A, Peyrou, M, Gavalda-Navarro, A, Villarroya, J, Quesada-Lopez, T, Lorente-Poch, L, Sancho, J, Szymczak, F, Piron, A, Rodriguez-Fernandez, S, Carobbio, S, Goday, A, Domingo, P, Vidal-Puig, A, Giralt, M, Eizirik, DL, Villarroya, F, Cereijo, R. Adipose tissue plasticity in pheochromocytoma patients suggests a role of the splicing machinery in human adipose browning. iScience. 2023; 26(6)DOI:10.1016/j.isci.2023.106847. PMID:37250773. IF:4.600(Q1/2D).

Pomar, V, Benito, N, Duch, P, Colome, M, Rivera, A, Domingo, P. Acute Bacterial Meningitis in Healthy Adult Patients: A Prospective Cohort Study. Journal of Clinical Medicine. 2023; 12(11)DOI:10.3390/jcm12113624. PMID:37297818. IF:3.000(Q1/2D).

Sempere, A, Assoumou, L, Gonzalez-Cordon, A, Waters, L, Rusconi, S, Domingo, P, Gompels, M, de Wit, S, Raffi, F, Stephan, C, Masia, M, Rockstroh, J, Katlama, C, Behrens, GMN, Moyle, G, Johnson, M, Fox, J, Stellbrink, HJ, Guaraldi, G, Florence, E, Esser, S, Gatell, J, Pozniak, A, Martinez, E. Incidence of Hypertension and Blood Pressure Changes in Persons With Human Immunodeficiency Virus (HIV) at High Risk for Cardiovascular Disease Switching From Boosted Protease Inhibitors to Dolutegravir: A Post-hoc Analysis of the 96-week Randomised NEAT-022 Trial. CLINICAL INFECTIOUS DISEASES. 2023; 77(7)DOI:10.1093/cid/ciad297. PMID:37207617. IF:8.200(Q1/1D).

Diaz, M, Mestres-Arenas, A, Lerin, C, Cereijo, R, Lopez-Bermejo, A, de Zegher, F, Villarroya, F, Ibanez, L. Circulating progranulin in human infants: relation to prenatal growth and early postnatal nutrition. PEDIATRIC RESEARCH. 2023; 94(3)DOI:10.1038/s41390-023-02595-1. PMID:37031297. IF:3.100(Q1/2D).

Palacio-Vieira J., Moreno-Fornés S., Díaz Y., Aceitón J., Bruguera A., Nomah D.K., Llibre J.M., Knobel H., Chivite I., Miro J.M., Domingo P., Suanzes P., Fanjul F., Navarro G., Macorigh L., Mera A., Casabona J., Imaz A., Reyes-Urueña J.. Who is lost to follow-up in HIV care? Assessment of care retention over time and the impact of COVID-19. Longitudinal analysis of the PISCIS cohort. HIV MEDICINE. 2023; 24(9)DOI:10.1111/hiv.13486. PMID:36990962. IF:2.800(Q2/5D).

Garcia-Beltran, C, Navarro-Gascon, A, Lopez-Bermejo, A, Quesada-Lopez, T, de Zegher, F, Ibanez, L, Villarroya, F. Meteorin-like levels are associated with active brown adipose tissue in early infancy. Frontiers in Endocrinology. 2023; 14DOI:10.3389/fendo.2023.1136245. PMID:36936161. IF:3.900(Q2/3D).

Waters, L, Assoumou, L, Gonzalez-Cordon, A, Rusconi, S, Domingo, P, Gompels, M, de Wit, S, Raffi, F, Stephan, C, Masia, M, Rockstroh, J, Katlama, C, Behrens, GMN, Moyle, G, Johnson, M, Fox, J, Stellbrink, HJ, Guaraldi, G, Florence, E, Esser, S, Gatell, JM, Pozniak, A, Martinez, E. Limited Weight Impact After Switching From Boosted Protease Inhibitors to Dolutegravir in Persons With Human Immunodeficiency Virus With High Cardiovascular Risk: A Post Hoc Analysis of the 96-Week NEAT-022 Randomized Trial. CLINICAL INFECTIOUS DISEASES. 2023; 76(5)DOI:10.1093/cid/ciac827. PMID:36259527. IF:8.200(Q1/1D).

Berenguer J., Jarrín I., Bellón J.M., Díez C., Jiménez-Sousa M.A., Roca C., González-García J., Dalmau D., Olalla J., Herrero C., Villarroya F., Domingo P., Resino S.. Obesity-Related Single-Nucleotide Polymorphisms and Weight Gain following First-Line Antiretroviral Therapy. CLINICAL INFECTIOUS DISEASES. 2023; 76(6)DOI:10.1093/cid/ciac880. PMID:36345912. IF:(Q/D).

Martín-Iguacel R., Vazquez-Friol M.C., Burgos J., Bruguera A., Reyes-Urueña J., Moreno-Fornés S., Aceitón J., Díaz Y., Domingo P., Saumoy M., Knobel H., Dalmau D., Borjabad B., Johansen I.S., Miro J.M., Casabona J., Llibre J.M.. Cardiovascular events in delayed presentation of HIV: the prospective PISCIS cohort study. Frontiers in Medicine. 2023; 10DOI:10.3389/fmed.2023.1182359. PMID:37415770. IF:3.100(Q1/2D).

Castro, A, Diaz, P, Domingo, P, Garcia-Yubero, C, Losa-Garcia, JE, Castro, A, Vidal-Vilar, N, Aceituno, S. Analysis of the costs associated with the follow-up of HIV patients discontinuing antiretroviral treatment due to lack of effectiveness or unacceptable toxicity in Spain. Farmacia Hospitalaria. 2022; 46(6)DOI:10.7399/fh.13038. PMID:36520571. IF:(Q/D).

Domingo, P, Quesada-Lopez, T, Villarroya, J, Cairo, M, Gutierrez, MD, Mateo, MG, Mur, I, Corbacho, N, Domingo, JC, Villarroya, F, Giralt, M. Differential effects of dolutegravir, bictegravir and raltegravir in adipokines and inflammation markers on human adipocytes. LIFE SCIENCES. 2022; 308DOI:10.1016/j.lfs.2022.120948. PMID:36096241. IF:6.100(Q1/2D).

Munoz-Rodriguez, J, Millan-Revilla, L. The role of nurses in the prevention of anal cancer in HIV- infected men having sex with men - a focus on papillomavirus vaccination and anal cytology screening. AIDS REVIEWS. 2022; 24(4)DOI:10.24875/AIDSRev.M22000053. PMID:36580603. IF:2.200(Q4/8D).

Cozzi-Lepri A., Peters L., Pelchen-Matthews A., Neesgaard B., Stephan C., Elbirt D., Brännström J., Paduta D., Trofimova T., Szlavik J., Van Eygen V., Pai H., Lundgren J., Harxhi A., Losso M., Kundro M., Schmied B., Karpov I., Vassilenko A., Paduto D., Mitsura V.M., Clumeck N., De Wit S., Delforge M., Hadziosmanovic V., Begovac J., Machala L., Jilich D., Gerstoft J., Pedersen C., Sedlacek D., Kronborg G., Benfield T., Johansen I.S., Ostergaard L., Wiese L., Moller N.F., Nielsen L.N., Zilmer K., Smidt J., Aho I., Viard J.P., Girard P.M., Pradier C., Fontas E., Duvivier C., Rockstroh J., Degen O., Hoffmann C., Stellbrink H.J., Stefan C., Bogner J., Fätkenheuer G., Chkhartishvili N., Sambatakou H., Adamis G., Paissios N., Uzdaviniene V., Staub T., Dragas S., Reiss P., Trajanovska J., Reikvam D.H., Maeland A., Bruun J., Knysz B., Szetela B., Inglot M., Bakowska E., Flisiak R., Grzeszczuk A., Parczewski M., Maciejewska K., Aksak-Was B., Beniowski M., Mularska E., Jablonowska E., Kamerys J., Wojcik K., Mozer-Lisewska I., Rozplochowski B., Zagalo A., Radoi R., Oprea C., Yakovlev A., Trofimora T., Khromova I., Kuzovatova E., Borodulina E., Vdoushkina E., Ranin J., Tomazic J., Miro J.M., Laguno M., Martinez E., Garcia F., Blanco J.L., Martinez-Rebollar M., Mallolas J., Callau P., Rojas J., Moreno S., del Campo S., Jou A., Paredes R., Puig J., Llibre J.M., Santos J.R., Domingo P., Gutierrez M., Mateo G.M., Sambeat A., Laporte J.M., Svedhem V., Thalme A., Sonnerborg A., Flamholc L., Kusejko K., Weber R., Calmy A., Furrer H., Battegay M., Schmid P., Kuznetsova A., Mikhalik J., Sluzhynska M., Milinkovic A., Johnson A.M., Simons E., Edwards S., Phillips A.M., Johnson A., Mocroft A., Orkin C., Winston A., Clarke A., Leen C.. Observational cohort study of rilpivirine (RPV) utilization in Europe. AIDS Research and Therapy. 2022; 19(1)DOI:10.1186/s12981-022-00457-0. PMID:35933352. IF:2.200(Q4/8D).

Martin-Iguacel R., Reyes-Urueña J., Bruguera A., Aceitón J., Díaz Y., Moreno-Fornés S., Domingo P., Burgos-Cibrian J., Tiraboschi J.M., Johansen I.S., Álvarez H., Miró J.M., Casabona J., Llibre J.M.. Determinants of long-term survival in late HIV presenters: The prospective PISCIS cohort study. Eclinicalmedicine. 2022; 52DOI:10.1016/j.eclinm.2022.101600. PMID:35958520. IF:15.100(Q1/1D).

Garreta E., Prado P., Stanifer M.L., Monteil V., Marco A., Ullate-Agote A., Moya-Rull D., Vilas-Zornoza A., Tarantino C., Romero J.P., Jonsson G., Oria R., Leopoldi A., Hagelkruys A., Gallo M., González F., Domingo-Pedrol P., Gavaldà A., del Pozo C.H., Hasan Ali O., Ventura-Aguiar P., Campistol J.M., Prosper F., Mirazimi A., Boulant S., Penninger J.M., Montserrat N.. A diabetic milieu increases ACE2 expression and cellular susceptibility to SARS-CoV-2 infections in human kidney organoids and patient cells. Cell Metabolism. 2022; 34(6)DOI:10.1016/j.cmet.2022.04.009. PMID:35561674. IF:29.000(Q1/1D).